ACM Global Receives Top Accreditation Renewal from College of American Pathologists
ACM Global Central Laboratory, a central lab that specializes in delivering high quality testing services designed to optimize clinical trial outcomes, has renewed its College of American Pathologists (CAP) accreditation based on the results of a recent onsite inspection.
ACM Global Central Laboratory
, a central lab that specializes in delivering high quality testing services designed to optimize clinical trial outcomes, has renewed its College of American Pathologists (CAP) accreditation based on the results of a recent onsite inspection.
The College of American Pathology conducted its biennial assessment of ACM U.S. laboratory and pathology operations and found no deficiencies at the company’s laboratory facilities in Rochester, New York. Inspection processes consists of examining quality control procedures and lab records including staff qualifications, equipment, health and safety along with the overall management of the facility. This rigorous process is designed to ensure the highest standard of care for all laboratory patients of central labs worldwide, and is considered equal or more stringent than the U.S. federal government’s own inspection program.
“The CAP survey process is a rigorous, peer-to-peer assessment of our quality and technical proficiency across a comprehensive range of standards. Maintaining this accreditation clearly demonstrates our dedication to high level performance and best practices as a central lab,” said John D’Souza, MD, laboratory director.
To view a complete list of credentials, please visit the site at
www.acmgloballab.com/credentials.aspx
or visit us at
DIA 2013, booth #945
, June 24-28 for more information.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
